Direct Oral Anticoagulants in Cancer Patients. Time for a Change in Paradigm

Direct Oral Anticoagulants in Cancer Patients. Time for a Change in Paradigm

Thrombosis is a more common occurrence in cancer patients compared to the general population and is one of the main causes of death in these patients. Low molecular weight heparin (LMWH) has been the recognized standard treatment for more than a decade, both in cancer-related thrombosis and in its p...

Full description

Bibliographic Details
Main Authors: Marek Z. Wojtukiewicz, Piotr Skalij, Piotr Tokajuk, Barbara Politynska, Anna M. Wojtukiewicz, Stephanie C. Tucker, Kenneth V. Honn
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Cancers
Subjects:
thrombosis
cancer
treatment
prophylaxis
anticoagulants
DOAC
Online Access:https://www.mdpi.com/2072-6694/12/5/1144

Similar Items

Similar Items